Concepedia

Publication | Open Access

DURATION‐2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once‐weekly exenatide

DOIFull Paper Access

117

Citations

12

References

2011

Year

Carol Wysham, Richard M. Bergenstal, Jaret Malloy, Ping Yan, Brandon Walsh, James Malone, Kathryn Taylor
Diabetic Medicine

Abstract

Patients who switched to once-weekly exenatide from daily sitagliptin or pioglitazone had improved or sustained glycaemic control, with weight loss.

References

YearCitations

Page 1